1992
DOI: 10.1001/archneur.1992.00530360098025
|View full text |Cite
|
Sign up to set email alerts
|

Suicide and Patients With Neurologic Diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
58
0
1

Year Published

2000
2000
2014
2014

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 88 publications
(59 citation statements)
references
References 46 publications
0
58
0
1
Order By: Relevance
“…The combination may ultimately lead to suicide. Investigators in Denmark showed that the cumulative lifetime risk for suicide from onset of MS was nearly twice that expected (standardized mortality ratio = 1.85) [99]. Suicide was the cause of 15 percent of deaths in a long-term followup study in Canada between 1972 and 1988 [100].…”
Section: Suicide and Multiple Sclerosismentioning
confidence: 97%
“…The combination may ultimately lead to suicide. Investigators in Denmark showed that the cumulative lifetime risk for suicide from onset of MS was nearly twice that expected (standardized mortality ratio = 1.85) [99]. Suicide was the cause of 15 percent of deaths in a long-term followup study in Canada between 1972 and 1988 [100].…”
Section: Suicide and Multiple Sclerosismentioning
confidence: 97%
“…Delayed-onset suicidal plans have also been found to be associated with greater physical impairment [3]in contrast to acute-onset plans [2], suggesting that the etiology of these two types of suicidal plans may be different. In addition, an increased suicide risk has been found in patients suffering from other neurological disorders including multiple sclerosis and spinal cord lesions as well as in selected groups of patients with epilepsy [4]. In other neurological diseases, the suicide risk may be increased, but the results are uncertain due to the methodological problems in the study design [4].…”
Section: Introductionmentioning
confidence: 99%
“…1,2 Undetected and untreated mental illness may worsen functioning 3 and quality of life, [4][5][6][7][8] decrease treatment adherence, 9 and increase risk of suicide. [10][11][12][13][14][15][16] Improved detection, diagnosis, and treatment practices in medical settings where individuals with emotional disorders are often first seen would help ameliorate these negative outcomes. This guideline reviews the evidence and makes recommendations for identifying, diagnosing, and treating psychiatric disorders in individuals with MS.…”
mentioning
confidence: 99%
“…31 Suicide may be at least twice as common. [10][11][12][13][14][15][16] Prevalence estimates for pseudobulbar affect (PBA) range from 6.5% to 46.2% [32][33][34] ; the prevalence of euphoria is unknown. 35 Depressive and manic/hypomanic symptoms may occur with high-dose corticosteroids, 36 but the association between depressed mood and disease-modifying therapies is unclear.…”
mentioning
confidence: 99%